Supplementary Figure S1 | Efficiency and specificity of araf-MOs. (a) The expression of the araf-5'UTR-EGFP reporter was efficiently inhibited by araf-MOs. The 5' UTR and adjacent 467-bp coding sequence of araf were amplified and cloned into the expression vector pEGFP-N3 to generate the reporter paraf-5'UTR-EGFP. Embryos injected alone with 80 pg of paraf-5'UTR-EGFP at the one-cell stage showed strong EGFP at midgastrulation stages. Co-injection with 20 ng araf-MO1, 10 ng araf-MO2 or 20 ng araf-MOs (10 ng araf-MO1 plus 10 ng araf-MO2) efficiently blocked EGFP expression, suggesting that either single or mixed MOs are effective. (b) araf-MO1 and araf-MO2 had similar effect on marker expression. Wild-type embryos at the one-cell stage were injected with 10 ng araf-MO1, araf-MO2 or both (each at 10 ng) and examined for the expression of the organizer-specific marker chordin and the ventral margin marker eve1 at the shield stage by whole-mount in situ hybridization. The shown were dorsal views for chordin and animal-pole views with dorsal to the right for
eve1. Note that araf knockdown by either morpholino expanded chordin but reduced eve1 expression domain, and that mixed morpholinos showed a better effect. (c) araf knockdown effect could be inhibited by araf mRNA overexpression. Embryos injected with 20 ng araf-MOs at the one-cell stage exhibited an elongated, ovoid shape, a dorsalized morphology. However, this morphological alteration was alleviated by co-injection with 300 pg of araf mRNA, suggesting the specificity of araf-MOs.
Supplementary Figure S2 | Expansion of mesendodermal marker expression and quantitative RT-PCR results of marker expression in araf morphants.
(a) araf morphants had more tiers of mesendoderm progenitors in blastodermal margin. Embryos in situ hybridized for sanil1a or gata5 expression at the shield stage were cryosectioned along the animal-vegetal axis and the number of tiers of positive cells was counted under a microscope. The sections were positioned with dorsal to the right and animal pole to the top. The boxed area was enlarged on the right. The numbers of positive tiers in the control and araf morphants were compared in the right bar graph. (b) qRT-PCR results of marker expression. Embryos were injected with control morpholino (cMO) or araf-MOs at the one-cell stage and collected at the indicated stages for qRT-PCR analysis with specific primers. Statistical significane: *, p < 0.05; **, p < 0.01. The embryos at the one-cell stage were injected with lefty1 mRNA or araf-MOs alone or together, and fixed at the shield stage for in situ hybridization with indicated probes. Embryos for chd expression were dorsal views with animal pole to the top, those for gata2 expression were animal-pole views with dorsal to the right, and those for gata5 and sox32 were also animal-pole views but did not have a uniform dorsoventral orientation.
Supplementary

Supplementary Figure S5 | Expanded mesendoderm marker expression by araf
knockdown could not be antagonized by erk2 overexpression. (a-c) Alteration of marker gene expression. One-cell stage embryos were injected with 20 ng standard control morpholino (scMO) or araf-MOs alone, or in combination with an indicated dose of erk2 mRNA. The injected embryos were fixed at the shield stage for examination of the mesodermal marker snail1 (a), the mesendodermal marker gata5 (b) and the endoderm marker sox32 (c) by whole-mount in situ hybridization. Embryos were lateral views with animal pole to the top and dorsal to the right. (a'-c') The ratio of embryos with altered marker expression. n, the number of observed embryos. (d) Detection of Erk and p-Erk proteins in injected embryos. The injected embryos were collected at the shied stage and lysed for Western blotting using anti-Erk or anti-p-Erk antibody. On the left were the Western blots. The related protein levels were measured by Image J analysis and shown on the right bar graph. The p-Erk level in lane 6 was statistically higher than that in lane 1 at p < 0.05; the p-Erk level in lanes 3-5 was statistically higher than that in lane 1 at p < 0.01; the difference of p-Erk level between lane 1 and 2 was not statistically significant (p > 0.05). The difference of p-Erk/total Erk ratio was not statistically significant among different lanes. Figure S6 | Decrease of p-Smad1/5/8C levels in araf morphants is reversed by co-knockdown of chd. Embryos were injected with indicted morpholino(s) at the one-cell stage and collected at the shield stage for Western blotting or immunostaining with corresponding antibodies. (a) Detection of p-Smad1/5/8C by Western blotting. Western blots were shown on the top panel, and the relative p-Smad1/5/8C levels were the ratios of p-Smad1/5/8C to total Smad1 and shown in the bottom bar graph. *, p < 0.05. (b) Immunostaining results using anti-p-Smad1/5/8C antibody. All images were animal-pole views with dorsal to the right. Supplementary Figure S10 | Araf preferentially binds to activated Smad2 with phosphorylated C-terminal SXS motif. HEK293T cells were transfected with indicated expression constructs and co-immunoprecipitation was performed. Both Araf and Smad2 were of the zebrafish origin. Note that Araf bound to much more Smad2(S466/468D), a phospho-mimetic mutant, than wild-type (WT) Smad2, while it hardly associated with the phospho-resistant mutant Smad2(S466/468A).
Supplementary
Supplementary Figure S11 | Effect of Smad2 mutants with different mutated residues in the linker region on linker phosphorylation recognized by anti-phospho-Smad2(Ser245/250/255) antibody. (a) Western blots using indicated antibodies. Smad2 mutants were generated using Smad2 of the zebrafish origin. Araf was also of the zebrafish origin. The anti-phospho-Smad2(Ser245/250/255) antibody (a-p-Smad2L antibody) presumably recognizes S246/251/256 phosphorylation of zebrafish Smad2. (b) Relative p-Smad2L levels were the ratios of p-Smad2L/total Smad2, which were measured by Image J analysis.
Supplementary Figure S12 | The linker phosphorylation of human SMAD2 by ARAF requires thr252. HA-ARAF and HA-tagged wild-type or mutant human SMAD2 were transfected into HEK293 cells and examined by Western blotting with appropriate antibodies. In particular, anti-p-SMAD2L antibody recognizes human SMAD2 phosphorylated at Ser245/250/255. Note that SMAD2(T252A) showed a marked reduction of linker phosphorylation.
Supplementary Figure S13 | Comparison of Smad2 levels between smad2-and smad2(S253A)-injected embryos. Embryos at one-cell stage were injected with 150 pg GFP mRNA and 400 pg wild-type smad2 or smad2(S253A) mRNA, and collected at 75% epiboly stage for examining Smad2 and GFP levels using anti-Smad2/3 and anti-GFP antibodies by Western blotting (a). The relative Smad2 levels were the ratios of Smad2/GFP (b), measured by Image J analysis.
Supplementary Figure S14 | Knockdown effect of braf and raf1a in zebrafish embryos.
(a) Efficiency test of braf-MO. The 5' UTR and adjacent 224-bp coding sequence of braf were amplified and cloned into the expression vector pEGFP-N3 to generate the reporter pbraf-5'UTR-EGFP. Embryos injected alone with 50 pg of pbraf-5'UTR-EGFP at the one-cell stage showed strong EGFP at midgastrulation stages. Co-injection with 5 ng braf-MO efficiently blocked EGFP expression, indicative of effectiveness. (b, c) Knockdown of braf or raf1a did not change Smad2 and Smad1 phosphorylation levels. Wild-type embryos at the one-cell stage were injected and examined for levels of indicated proteins at the 75% epiboly stage by Western blotting using corresponding antibodies. The ratios of phosphorylated proteins were shown in (c), which were calculated based on scanned densities from two independent experiments. (d) Knockdown of braf, raf1a or both did not alter gata5 and sox32 expression. Wild-type embryos at the one-cell stage were injected and examined for the expression of the mesendoderm marker gata5 and the endoderm marker sox32 at the shield stage. The ratios of embryos with the showed phenotype were indicated. Western blots were shown on the left and the calculated relative p-SMAD2C levels were shown on the right. Cells were harvested one hour before (-1 h), at (0 h) and one hour (1 h) after stimulation with TGF-β1 (2.5 ng/ml). (e) Transfection of Araf KD impeded TGF-1-stimulated nuclear accumulation of endogenous Smad2 in HeLa cells. The ratio shown in the right bottom image was the number of transfected cells with reduced nuclear Smad2/the number of transfected cells. The endogenous Smad2 and transfected HA-Araf KD were detected by immunostaining using anti-Smad2/3 and anti-HA antibodies respectively.
Supplementary Figure S16 | Overexpression of araf KD antagonizes the effects of ectopic sqt in mesendoderm induction and patterning. Embryos were injected with indicated mRNA species at the one-cell stage and examined for the expression of the indicated markers at the shield stage by whole-mount in situ hybridization. (a) in situ hybridized embryos. Images for ntl, sox32 and eve1 were animal-cap views, those for gata5 were lateral views with animal pole to the top and those for gsc were dorsal views with animal pole to the top. (b) Statistical data showed the percentages of embryos with altered marker expression. n, the total number of observed embryos.
Supplementary Figure S17 | Potential role of Araf in regulating different Smads. (a)
Association of Araf with different human SMADS. GST-tagged zebrafish Araf expression construct was co-transfected with human SMAD constructs into HEK293T cells. Co-immunoprecipitation analysis was performed to detect their association. (b) GST-Araf expressed in HEK293T cells did not associate with co-expressed Flag-SMAD6 or Flag-SMAD7. (c) Zebrafish Araf associated with zebrafish Smad3a and Smad3b. The expression constructs were transfected into HEK293T cells and co-immunoprecipitation was performed. (d) Araf phosphorylated distinct Smads. Zebrafish wild-type Araf (WT) or mutant Araf KD (KD), Smad1, Smad2, Smad2(S253A), Smad3a and Smad3b, and human SMAD4 were expressed in bacterial cells and purified. Corresponding purified proteins were mixed and incubated in the presence of -32 P-labeled ATP. The incubated mixtures were resolved by SDS-PAGE and exposed to an X-ray film. Araf and Smad inputs were examined by Coomassie blue staining. The experiments were repeated three times and reproducible results were obtained. The results indicated that Araf phosphorylates Smad2 efficiently and it may also phosphorylate Smad1 less efficiently. (e) Araf had little effect on the stability of TGF-1-activated Smad3 (p-Smad3C). Hep3B cells transfected with HA-Araf were stimulated with the addition of TGF-1 and harvested at different time points to detect the levels of different endogenous proteins and HA-Araf using appropriate antibodies by Western blotting. The relative p-SMAD3C levels (p-SMAD3C/total SMAD3) were calculated by Image J analysis and shown on the right bar graph. the proteinase inhibitor cocktail (Roche). In case that the phosphorylated proteins needed to be detected, 100 mM NaF and 1 mM sodium peroxyvanadate (NaVO4) were added to the TNE lysis buffer. The lysates were run on SDS-PAGE and blotted with corresponding antibodies. The number of embryos used for each gel lane was 10 to 60 depending on the abundance of examined proteins.
For co-immunoprecipitation, about 300 embryos were injected at the one-cell stage with HA-tagged araf mRNA at a dose of 300 pg, and harvested at 75% epiboly stage with 300 μl TNE lysis buffer. The overexpressed HA-Araf was immunoprecipitated with anti-HA antibody (Santa Cruz) and Smad2 protein present in the immunoprecipitates was detected by Western blotting using anti-Smad2/3 antibody (Cell Signaling Technology). The anti-Smad2/3 antibody reacted with zebrafish Smad2 only 8 .
Immunostaining in zebrafish embryos. For immunostaining of p-Smad1/5/8 in embryos, Wild-type or microinjected embryos were collected at the shield stage, fixed in 4% paraformaldehyde at 4 o C overnight, dehydrated using methanol and stored at -20 o C. The embryos were rehydrated using PBS and boiled in 1 mM EDTA (pH 8.0) for about 10 min to repair the antigen. After cooling at room temperature, the embryos were blocked with 3% BSA, 5% FBS and 1% DMSO in PBS for more than 1 h at room temperature, followed by incubation with anti-p-Smad1/5/8 or anti-phospho-Erk antibody overnight. The embryos were washed with PBS containing 3% BSA and 1% DMSO for 30 min and blocked again, followed by incubation with a relevant DyLight Fluors-labeled secondary antibody overnight. The nuclei were stained with DAPI. The fluorescence images were acquired under a Zeiss710META confocal microscope.
